Stockscreener 앱 받기
3.94
1.81%
0.07
Larimar Therapeutics Inc (LRMR) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
10.89%
27.79
|
31.19 | 31.29 | 18.26 | 24.60 |
| Operating Income/Loss |
10.89%
-27.79
|
-31.19 | -31.29 | -18.26 | -24.60 |
| Nonoperating Income/Loss |
15.57%
1.61
|
1.907 | 2.469 | 2.765 | 2.972 |
| Income/Loss From Continuing Operations Before Tax |
10.58%
-26.18
|
-29.28 | -28.82 | -15.50 | -21.63 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
10.58%
-26.18
|
-29.28 | -28.82 | -15.50 | -21.63 |
|
Net Income/Loss
|
10.58%
-26.18
|
-29.28 | -28.82 | -15.50 | -21.63 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.10%
64.03
|
63.96 | 0.8564 | 63.81 | 63.80 |
| Diluted Average Shares |
0.10%
64.03
|
63.96 | 0.8564 | 63.81 | 63.80 |
| Basic Earnings Per Share |
10.87%
-0.41
|
-0.46 | -0.46 | -0.24 | -0.34 |
| Diluted Earnings Per Share |
10.87%
-0.41
|
-0.46 | -0.46 | -0.24 | -0.34 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
자본화:
|
볼륨(24시간):